Reducing neonatal morbidity by discontinuing oxytocin during the active phase of first stage of labor: a multicenter randomized controlled trial STOPOXY

Reducing neonatal morbidity by discontinuing oxytocin during the active phase of first stage of labor: a multicenter randomized controlled trial STOPOXY

Abstract Background Oxytocin is effective in reducing labor duration, but can be associated with fetal and maternal complications such as neonatal acidosis and post-partum hemorrhage. When comparing discontinuing oxytocin in the active phase with continuing oxytocin infusion, previous studies were u...

Full description

Bibliographic Details
Main Authors: Aude Girault, François Goffinet, Camille Le Ray, on behalf of the collaborators of the STOPOXY trial and the Groupe de Recherche en Obstétrique et Gynécologie (GROG)
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Pregnancy and Childbirth
Subjects:
Oxytocin
Discontinuation
Neonatal morbidity
Cesarean delivery
Labor duration
Birth experience
Online Access:http://link.springer.com/article/10.1186/s12884-020-03331-x

Internet

http://link.springer.com/article/10.1186/s12884-020-03331-x

Similar Items